Anaesthesia & intensive care medicine
Volume 11, Issue 9 , Pages 340-342, September 2010

Ischaemic stroke

Robin Howard PhD FRCP is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and at St Thomas’ Hospital, London and an Honorary Senior Lecturer at the Institute of Neurology, London. His special interests include neuromedical intensive care and he has published widely on the subject. Conflicts of interest: none declared

Abstract 

Stroke is a clinical syndrome caused by a sudden loss of blood flow to a specific area of the brain. In 85% of cases it is due to cerebral vessel thrombosis or embolism resulting in focal ischaemia. If administered soon after the onset of symptoms thrombolytic therapy can reverse neurological deficit due to ischaemic stroke.

Keywords: Antiplatelet drugs, stroke, thrombolysis, transient ischaemic attack

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1472-0299(10)00133-5

doi:10.1016/j.mpaic.2010.05.010

Anaesthesia & intensive care medicine
Volume 11, Issue 9 , Pages 340-342, September 2010

Article Tools

* Image Usage & Resolution